Weekly Roundup: May 17-20, 2021

POLL: What is the best plan of action for lip augmentation?

The Mainstream Patient: May 17, 2021

This week’s edition of The Mainstream Patient features stories on castor oil for hair growth, skin picking, reef safe sunscreens, biotin for acne, plus more.

Microneedling Differentiators

Ava Shamban, MD, discusses microneedling differentiators using the Vivace Microneedle RF device, combination therapies, and the importance of social media partnerships.

Masculinizing Hormone Therapy Linked to Acne Diagnosis

A cohort study investigated the association between MHT and acne diagnosis.

Off-label Biologics Target Wide Range of Skin Diseases

Novel biologics are moving into off-label indications to expand the dermatologic armamentarium for a broad range of inflammatory skin diseases.

Treatment Difference Between Dermatologists and Pediatricians

A study examined the difference in prescribing patterns between pediatricians and dermatologists when it came to acne treatments.

I Used Botulinum Toxin Injections for Oily Skin—Now I Have Been Sued

In this month's Legal Eagle article, David J. Goldberg, MD, JD, examines physicians being sued for using injectables for off-label procedures, such as for oily skin.

Current and Upcoming Topicals in the Pipeline for AD

Dermatologists have a variety of topicals to choose from, but other options are on the horizon to add to this armamentarium.

The Cutaneous Connection: Episode 23- Roundup of AAD VMX 2021

In this episode, we take a look back at what happened at the American Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), including exclusive interviews with two KOLs about their presentations regarding climate change and new data on biologics for psoriasis.

Master Techniques to Treat Eye Issues

In this month's Cosmetic Conundrums column, Chief Medical Editor of Dermatology Times®, Zoe Diana Draelos, MD, answers a few common questions on how to treat eye issues.

Emerging Biologics Make Waves in AD

A new generation of inhibitors take aim at key sources of inflammation.

Administrative Burden of Prescribing Biologics

Prescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.